- Home
- TAOP vs NBY Comparison
TAOP vs NBY Comparison
Compare TAOP & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- NBY
- Stock Information
- Founded
- TAOP 1993
- NBY 2000
- Country
- TAOP China
- NBY United States
- Employees
- TAOP N/A
- NBY N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- NBY
- Sector
- TAOP Technology
- NBY
- Exchange
- TAOP Nasdaq
- NBY Nasdaq
- Market Cap
- TAOP 3.3M
- NBY 2.8M
- IPO Year
- TAOP N/A
- NBY 2007
- Fundamental
- Price
- TAOP $0.32
- NBY $0.63
- Analyst Decision
- TAOP
- NBY Strong Buy
- Analyst Count
- TAOP 0
- NBY 1
- Target Price
- TAOP N/A
- NBY $0.85
- AVG Volume (30 Days)
- TAOP 983.2K
- NBY 107.9K
- Earning Date
- TAOP 09-05-2024
- NBY 03-25-2025
- Dividend Yield
- TAOP N/A
- NBY N/A
- EPS Growth
- TAOP N/A
- NBY N/A
- EPS
- TAOP 0.50
- NBY N/A
- Revenue
- TAOP $42,636,173.00
- NBY $13,844,000.00
- Revenue This Year
- TAOP N/A
- NBY N/A
- Revenue Next Year
- TAOP N/A
- NBY $11.73
- P/E Ratio
- TAOP $0.50
- NBY N/A
- Revenue Growth
- TAOP 37.49
- NBY 15.40
- 52 Week Low
- TAOP $0.23
- NBY $0.07
- 52 Week High
- TAOP $1.39
- NBY $6.30
- Technical
- Relative Strength Index (RSI)
- TAOP 54.56
- NBY 44.89
- Support Level
- TAOP $0.28
- NBY $0.61
- Resistance Level
- TAOP $0.34
- NBY $0.71
- Average True Range (ATR)
- TAOP 0.03
- NBY 0.05
- MACD
- TAOP 0.01
- NBY -0.01
- Stochastic Oscillator
- TAOP 75.50
- NBY 27.27
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.